Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: J Am Geriatr Soc. 2018 Oct 16;66(12):2321–2326. doi: 10.1111/jgs.15583

Table 1.

Characteristics of the older liver transplant (LT) recipients from 2003–2016.

Characteristic 2003–2006 2007–2009 2010– 06/18/2013 06/19/2013– 2016 P value
N=1453 N=1544 N=2222 N=3408
Recipient characteristic
Age (years), mean± SD 68.0± 2.7 67.8± 2.6 67.8± 2.5 67.6± 2.4 .001
Female, % 38.9 37.2 36.9 34.0 .006
BMI, mean± SD 27.4± 4.9 27.9± 5.3 28.0± 5.1 28.4± 5.1 <.001
Race, %
    White 77.7 74.1 73.8 73.8 <.001
    African American 3.9 5.1 6.7 7.8
Indication for LT, %
    Hepatitis C virus cirrhosis 16.5 12.6 15.8 18.1 <.001
    Alcoholic cirrhosis 12.6 14.1 12.7 13.0
    Non-alcoholic steatohepatitis 5.8 13.0 14.2 19.5
    Hepatocellular carcinoma 18.4 27.9 29.1 28.9
    Cholestatic liver disease 10.0 8.3 7.8 6.7
    Non-cholestatic cirrhosis 26.4 18.2 13.8 8.6
MELD, %
    <10 3.0 1.4 0.6 0.4 <.001
    10–19 28.3 20.7 12.7 11.4
    20–29 53.8 62.7 58.3 52.9
    30–39 11.1 10.6 20.2 27.5
    ≥40 1.9 3.6 6.4 6.7
    Status 1/1A 1.9 1.1 1.7 1.2
Life support (prior to LT) 2.8 3.1 4.7 5.3 <.001
Ascites, % 2.0 2.0 2.0 1.9 .001
Albumin (g/dL) 1.1 1.1 1.1 1.2 <.001
Portal vein thrombosis, % 5.0 8.9 14.3 14.6 <.001
Comorbidities, %
    HIV 0.1 0.1 0.1 0.2 .79
    Hepatitis C 27.5 27.6 30.2 32.6 <.001
    Diabetes mellitus 31.0 34.5 33.5 37.4 <.001
Liver transplant characteristic
Cold ischemia time (hours), %
    0–8 72.3 80.6 88.4 88.5 <.001
    9–11 18.0 14.2 9.8 9.7
    ≥12 9.7 5.2 1.8 1.8
ABO incompatible, % 0.5 0.5 0.7 1.0 .08
Split graft, % 1.2 1.9 1.7 1.5 .37
Donor characteristic
Age, % <.001
    <18 6.2 6.2 5.1 5.1
    18–39 28.8 32.8 34.6 36.5
    40–49 18.7 17.5 16.9 17.1
    50–59 19.0 18.3 20.2 20.3
    60–69 15.4 13.8 15.0 14.3
    ≥70 12.0 11.5 8.2 6.7
Female, % 44.9 40.2 43.1 40.8 .02
Race, %
    White 71.6 64.4 66.0 65.7 <.001
    African American 14.3 17.2 19.4 18.8
Donation after cardiac death, % 4.8 6.4 5.4 7.2 .003
Hepatitis C, % 1.2 1.8 2.3 5.3 <.001